Parallax products are designed to help make the percutaneous delivery of bone cement and bone biopsy procedures, safe and effective. Our innovative products are easy to set up and use, an advantage that ensures you and your patients are satisfied with the results every time.
Our acrylic bone cement products, Parallax Acrylic Resin with TRACERS® (Barium Sulfate opacifier) and Parallax Acrylic Resin with TRACERS-Ta (Tantalum opacifier) are specifically indicated for vertebroplasty and kyphoplasty procedures for the treatment of vertebral compression fractures due to Osteoporosis. Learn more about how vertebroplasty works and the early beginnings of the procedure.
Download patient education brochure or complete our online request form to request product literature.
Before 1995, pain associated with compression fractures was treated only with analgesics, bed rest and external bracing. However, these conservative measures are now considered the first line of treatment; for many patients the pain is severe and continues for weeks or months in spite of initial treatment.
Deramond and Galibert, in Amiens, France, first performed a percutaneous vertebral augmentation in 1984. Their patient had severe pain from an aggressive hemangioma involving the C2 vertebra. Using fluoroscopic guidance, Dr. Deramond placed a large bore needle into the C2 vertebral body and infused polymethylmethacrylate, relieving the patient's pain completely. Soon, the indications were broadened by Desquenel to include patients treated for pain resulting from vertebral collapse secondary to osteoporosis or malignant infiltration. Deramond and Galibert reported their first seven procedures in 1987, and called the procedure "percutaneous vertebroplasty."
Osteoporosis (age-related loss of bone density) is the most common etiology of vertebral compression fractures. Over 700,000 people are diagnosed each year with VCF's and most over age 50. Learn more about this disease and treatment on www.fracturerelief.com
